|
|||||||||||||||||||||||||||||||||||||||||
Jens
Eichhorn, MD. Jens was born and raised in Berlin, Germany. He received his medical degree from Humboldt University (Berlin, Germany) in 1993. During his medical studies, Jens became interested in vessel wall biology. His thesis work, completed in 1995, focused on the role of Anti-Endothelial Cell Antibodies in patients with Takayasu arteritis and Buerger’s disease. Subsequently, Jens started training in Internal Medicine at Humboldt University’s Charité Hospitals. During that time, he investigated the role of adhesion molecules in patients with Wegener’s granulomatosis under guidance of Hermann Haller and Friedrich C. Luft. In 1995, Jens started a postdoctoral fellowship to study growth factor and adhesion molecule signaling. Jens joined Nicholas Webster’s and Jerrold M. Olefsky’s group at the University of California, San Diego to study the role of phospholipase C in insulin’s mitogenic and metabolic signal transduction pathways. In 1999, Jens decided to complete his training in General Internal Medicine at Tulane University (New Orleans, LA). During his residency, he worked in different patient settings including Charity Hospital in New Orleans, the largest public hospital in the United States.Jens is certified by the American Board of Internal Medicine. After finishing his
residency in 2002, Jens joined the fellowship program in Cardiovascular
Medicine at Stanford University (Palo Alto, CA). Jens currently works
in Thomas Quertermous lab on specific transcription factors important
for endothelial-vascular smooth muscle cell communication, tyrosine kinase
receptor and G-protein signaling. He is also participates in the SAPPHIRe
Study.
|
|
![]() |
|||||||||||||||||||||||||||||||||||||||
|
Other People : -
Euan Retired: |
|||||||||||||||||||||||||||||||||||||||||